Relationship between brain-derived neurotrophic factor and immune function during dietary supplement treatment of elderly with Alzheimer’s dementia
Background and Aim: The objective of the present study was to investigate the relationships among pro brain-derived neurotrophic factor (BDNF) and mature BDNF and immune functioning during aloe polymannose multinutrient complex (APMC) treatment in persons with moderate to severe Alzheimer’s dementia (AD).
Methods: An open label trial of twelve months was used to execute the study. Thirty-four adults with AD were enrolled and consumed 4 teaspoons/day of APMC for 12 months. Subjects were assessed at baseline and twelve months follow-up for proBDNF and BDNF and cytokines, growth factors, T-cell and B-cell subsets, and complete blood count to measure immune functioning. All biomarkers were inter-correlated.
Results: Several relationships were identified between proBDNF, BDNF, and BDNF/proBDNF ratio and immune function at 12 months, particularly BDNF with VEGF (r = 0.55, p = 0.03), EGF (r = 0.74, p = 0.001), and CD95+CD3+ (%) (r = –0.64, p = 0.03) and proBDNF with VEGF (r = 0.64, p = 0.02), EGF (r = 0.86, p < 0.001), and CD16+56+ (%) (r = –0.78, p < 0.01). Other correlations were noted for various immune function variables with BDNF, proBDNF, and/or BDNF/proBDNF ratio at baseline and 12 months. Dichotomizing subjects on BDNF above and below 5000 pg/mL revealed additional relationships with platelets and neutrophils.
Conclusions: The associations between BDNF and proBDNF and various immune markers, such as VEGF, EGF, and CD95+CD3+ ratio, provide insight into the link between neurological function and the immune system. These relationships were even stronger in response to APMC treatment, which lends support to previous findings showing improved immune function after dietary supplementation.
Relevance for patients: Alzheimer's dementia patients have conventional treatment options with limited efficacy for counteracting the deleterious effects of the disease on neurological function. The link between neurological and immune function has been understudied in this population. Overall, our results showed significant beneficial relationships between immune and neurological function, particularly in response to 12 months of treatment with an all-natural polysaccharide-based dietary supplement that is a known immunomodulator. Thus, the use of this dietary supplement may benefit these patients by simultaneously improving immune and neurological function.
[1] Xie H, Yung WH. Chronic Intermittent Hypoxia-induced Deficits in Synaptic Plasticity and Neurocognitive Functions: A Role for Brain-Derived Neurotrophic Factor. Acta Pharmacol Sin 2012;33:5-10.
[2] Meis S, Endres T, Lessmann V. Postsynaptic BDNF Signalling Regulates Long-term Potentiation at Thalamoamygdala Afferents. J Physiol 2012;590:193-208.
[3] Bramham CR, Messaoudi E. BDNF Function in Adult Synaptic Plasticity: The Synaptic Consolidation Hypothesis. Prog Neurobiol 2005;76:99-125.
[4] Nagahara AH, Merrill DA, Coppola G, Tsukada S, Schroeder BE, Shaked GM, et al. Neuroprotective Effects of Brain-derived Neurotrophic Factor in Rodent and Primate Models of Alzheimer’s Disease. Nat Med 2009;15:331-7.
[5] Islam O, Loo TX, Heese K. Brain-derived Neurotrophic Factor (BDNF) has Proliferative Effects on Neural Stem Cells through the Truncated TRK-B Receptor, MAP Kinase, AKT, and STAT-3 Signaling Pathways. Curr Neurovasc Res 2009;6:42-53.
[6] Schneider LS, Sano M. Current Alzheimer’s Disease Clinical Trials: Methods and Placebo Outcomes. Alzheimers Dement 2009;5:388-97.
[7] Mizui T, Ishikawa Y, Kumanogoh H, Lume M, Matsumoto T, Hara T, et al. BDNF Pro-peptide Actions Facilitate Hippocampal LTD and are Altered by the Common BDNF Polymorphism Val66Met. Proc Natl Acad Sci U S A 2015;112:E3067-74.
[8] Chao CC, Ma YL, Lee EH. Brain-derived Neurotrophic Factor Enhances Bcl-xL Expression through Protein Kinase Casein Kinase 2-Activated and Nuclear Factor Kappa B-mediated Pathway in Rat Hippocampus. Brain Pathol 2011;21:150-62.
[9] Cunha C, Brambilla R, Thomas KL. A Simple Role for BDNF in Learning and Memory? Front Mol Neurosci 2010;3:1.
[10] Kairisalo M, Korhonen L, Sepp M, Pruunsild P, Kukkonen JP, Kivinen J, et al. NF-kappaB-dependent Regulation of Brain-derived Neurotrophic Factor in Hippocampal Neurons by X-linked Inhibitor of Apoptosis Protein. Eur J Neurosci 2009;30:958-66.
[11] Marini AM, Jiang X, Wu X, Tian F, Zhu D, Okagaki P, et al. Role of Brain-derived Neurotrophic Factor and NFkappaB in Neuronal Plasticity and Survival: From Genes to Phenotype. Restor Neurol Neurosci 2004;22:121-30.
[12] Je HS, Yang F, Ji Y, Nagappan G, Hempstead BL, Lu B. Role of Pro-brain-derived Neurotrophic Factor (proBDNF) to Mature BDNF Conversion in Activity-dependent Competition at Developing Neuromuscular Synapses. Proc
[13] Lu B, Pang PT, Woo NH. The Yin and Yang of Neurotrophin Action. Nat Rev Neurosci 2005;6:603-14.
[14] Alzheimer’s Association. Alzheimer’s Disease Facts and Figures. Chicago, Illinois, United States: Alzheimer’s Association; 2017.
[15] Saha RN, Liu X, Pahan K. Up-regulation of BDNF in Astrocytes by TNF-Alpha: A Case for the Neuroprotective Role of Cytokine. J Neuroimmune Pharmacol 2006;1:212-22.
[16] Wang TY, Lee SY, Chen SL, Chang YH, Wang LJ, Chen PS, et al. Comparing Clinical Responses and the Biomarkers of BDNF and Cytokines between Subthreshold Bipolar Disorder and Bipolar II Disorder. Sci Rep 2016;6:27431.
[17] Rahvar M, Nikseresht M, Shafiee SM, Naghibalhossaini F, Rasti M, Panjehshahin MR, et al. Effect of Oral Resveratrol on the BDNF Gene Expression in the Hippocampus of the Rat Brain. Neurochem Res 2011;36:761-5.
[18] Wu A, Ying Z, Gomez-Pinilla F. Dietary Omega-3 Fatty Acids Normalize BDNF Levels, Reduce Oxidative Damage, and Counteract Learning Disability after Traumatic Brain Injury in Rats. J Neurotrauma 2004;21:1457-67.
[19] Liang S, Huang R, Lin X, Huang J, Huang Z, Liu H. Effects of Yulangsan Polysaccharide on Monoamine Neurotransmitters, Adenylate Cyclase Activity and Brainderived Neurotrophic Factor Expression in a Mouse Model of Depression Induced by Unpredictable Chronic Mild Stress. Neural Regen Res 2012;7:191-6.
[20] Nelson ED, Ramberg JE, Best T, Sinnott RA. Neurologic Effects of Exogenous Saccharides: A Review of Controlled Human, Animal, and In Vitro Studies. Nutr Neurosci 2012;15:149-62.
[21] Lewis JE, McDaniel HR, Agronin ME, Loewenstein DA, Riveros J, Mestre R, et al. The Effect of an Aloe Polymannose Multinutrient Complex on Cognitive and Immune Functioning in Alzheimer’s Disease. J Alzheimers Dis 2013;33:393-406.
[22] Ali K, Melillo A, Leonard S, Asthana D, Woolger J, Wolfson A, et al. An Open-label, Randomized Clinical Trial to Assess the Immunomodulatory Activity of a Novel Oligosaccharide Compound in Healthy Adults. Functional Foods in Health and Disease 2012;2:265-279.
[23] Lages LC, Lopez J, Lopez-Medrano AM, Atlas SE, Martinez AH, Woolger JM, et al. A Double-blind, Randomized Trial on the Effect of a Broad-spectrum Dietary Supplement on Key Biomarkers of Cellular aging Including Inflammation, Oxidative Stress, and DNA Damage in Healthy Adults. J Clin Transl Res 2017;2:135-43.
[24] Lewis JE, Melillo AB, Tiozzo E, Chen L, Leonard S, Howell M, et al. A Double-Blind, Randomized Clinical Trial of Dietary Supplementation on Cognitive and Immune Functioning in Healthy Older Adults. BMC Complement Altern Med 2014;14:43.
[25] Martin A, Stillman J, Miguez MJ, McDaniel HR, Konefal J, Woolger JM, et al. The Effect of Dietary Supplementation on Brain-derived Neurotrophic Factor and Cognitive Functioning in Alzheimer’s Dementia. J Clin Transl Res 2018;3:337-43.
[26] Fahnestock M, Marchese M, Head E, Pop V, Michalski B, Milgram WN, et al. BDNF Increases with Behavioral Enrichment and an Antioxidant Diet in the Aged Dog. Neurobiol Aging 2012;33:546-54.
[27] Folstein MF, Folstein SE, McHugh PR. “Mini-Mental State”. APractical Method for Grading the Cognitive State of Patients for the Clinician. J Psychiatr Res 1975;12:189-98.
[28] Teixeira AL, Barbosa IG, Diniz BS, Kummer A. Circulating Levels of Brain-derived Neurotrophic Factor: Correlation with Mood, Cognition and Motor Function. Biomark Med 2010;4:871-87.
[29] Sachdeva N, Yoon HS, Oshima K, Garcia D, Goodkin K, Asthana D. Biochip array-based Analysis of Plasma Cytokines in HIV Patients with Immunological and Virological Discordance. Scand J Immunol 2007;65:549-54.
[30] Chidlow JH Jr., Glawe JD, Alexander JS, Kevil CG. VEGF164 Differentially Regulates Neutrophil and T Cell Adhesion through ItgaL- and ItgaM-Dependent Mechanisms. Am J Physiol Gastrointest Liver Physiol 2010;299:G1361-7.
[31] Healy ME, Bergin R, Mahon BP, English K. Mesenchymal stromal Cells Protect Against Caspase 3-Mediated Apoptosis of CD19(+) Peripheral B cells Through ContactDependent Upregulation of VEGF. Stem Cells Dev 2015;24:2391-402.
[32] Kassan M, Ait-Aissa K, Ali M, Trebak M, Matrougui K. Augmented EGF Receptor Tyrosine Kinase Activity Impairs Vascular Function by NADPH Oxidase-Dependent Mechanism in Type 2 Diabetic Mouse. Biochim Biophys Acta 2015;1853:2404-10.
[33] Mulligan JK, Rosenzweig SA, Young MR. Tumor Secretion of VEGF Induces Endothelial Cells to Suppress T Cell Functions through the Production of PGE2. J Immunother 2010;33:126-35.
[34] Vial D, McKeown-Longo PJ. Role of EGFR Expression Levels in the Regulation of Integrin Function by EGF. Mol Carcinog 2016;55:1118-23.
[35] Zadran S, Jourdi H, Rostamiani K, Qin Q, Bi X, Baudry M. Brain-derived Neurotrophic Factor and Epidermal Growth Factor Activate Neuronal m-calpain via Mitogen-Activated Protein Kinase-dependent Phosphorylation. J Neurosci 2010;30:1086-95.
[36] Zhang Q, Liu G, Wu Y, Sha H, Zhang P, Jia J. BDNF Promotes EGF-induced Proliferation and Migration of Human Fetal Neural Stem/Progenitor Cells via the PI3K/ Akt Pathway. Molecules 2011;16:10146-56.
[37] Chen NN, Wang JP, Liu HF, Zhang M, Zhao YZ, Fu XJ, et al. The Bone Marrow Mononuclear Cells Reduce theOxidative Stress of Cerebral Infarction through PI3K/ AKT/NRF2 Signaling Pathway. Eur Rev Med Pharmacol Sci 2017;21:5729-35.
[38] Nagahara AH, Tuszynski MH. Potential Therapeutic Uses of BDNF in Neurological and Psychiatric Disorders. Nat Rev Drug Discov 2011;10:209-19.
[39] Li B, Gao Y, Zhang W, Xu JR. Regulation and Effects of Neurotrophic Factors after Neural Stem Cell Transplantation in a Transgenic Mouse Model of Alzheimer Disease. J Neurosci Res 2018;96:828-40.
[40] Tauber SC, Harms K, Falkenburger B, Weis J, Sellhaus B, Nau R, et al. Modulation of Hippocampal Neuroplasticity by Fas/CD95 Regulatory Protein 2 (Faim2) in the Course of Bacterial Meningitis. J Neuropathol Exp Neurol 2014;73:2-13.
[41] Reich A, Spering C, Schulz JB. Death Receptor Fas (CD95) Signaling in the Central Nervous System: Tuning Neuroplasticity? Trends Neurosci 2008;31:478-86.
[42] Vaisid T, Barnoy S, Kosower NS. Calpain Activates Caspase-8 in Neuron-like Differentiated PC12 Cells via the Amyloid-beta-peptide and CD95 Pathways. Int J Biochem Cell Biol 2009;41:2450-8.
[43] Chiappelli M, Nasi M, Cossarizza A, Porcellini E, TuminiE, Pinti M, et al. Polymorphisms of Fas Gene: Relationship with Alzheimer’s Disease and Cognitive Decline. Dement Geriatr Cogn Disord 2006;22:296-300.
[44] Jabir NR, Firoz CK, Ahmed F, Kamal MA, Hindawi S, Damanhouri GA, et al. Reduction in CD16/CD56 and CD16/CD3/CD56 Natural Killer Cells in Coronary Artery Disease. Immunol Invest 2017;46:526-35.
[45] Lübbers J, van Beers-Tas MH, Vosslamber S, Turk SA, de Ridder S, Mantel E, et al. Changes in Peripheral Blood Lymphocyte Subsets during Arthritis Development in Arthralgia Patients. Arthritis Res Ther 2016;18:205.
[46] Wang J, Han W, Gao Z, Wang Y, Wu L, Zhang J, et al. Elevation of CD16+ CD56+ NK-cells and Downregulation of Serum Interleukin-21 (IL-21) and IL- 1α after Splenectomy in Relapsed Hemophagocytic Lymphohistiocytosis of Unknown Cause. Hematology 2017;22:477-83.
[47] Schindowski K, Peters J, Gorriz C, Schramm U, WeinandiT, Leutner S, et al. Apoptosis of CD4+ T and Natural Killer Cells in Alzheimer’s Disease. Pharmacopsychiatry 2006;39:220-8.
[48] Laske C, Stransky E, Leyhe T, Eschweiler GW, Schott K, Langer H, et al. Decreased Brain-derived Neurotrophic Factor (BDNF) and Beta-thromboglobulin (beta-TG) Blood Levels in Alzheimer’s Disease. Thromb Haemost 2006;96:102-3.
[49] Zenaro E, Pietronigro E, Della Bianca V, Piacentino G, Marongiu L, Budui S, et al. Neutrophils Promote Alzheimer’s Disease-like Pathology and Cognitive Decline via LFA-1 Integrin. Nat Med 2015;21:880-6.